Health Care

Moderna stock falls more than 15% as it slashes guidance on low EU sales, tough U.S. vaccine market

Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion. 

adminadmin
Aug 1, 2024 - 21:00
 0  17
Moderna stock falls more than 15% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion. 
Read More

Tags:

Previous Article

Your health records are coming to new apps. Here's why

Next Article

Wayfair CEO likens home goods slowdown to 2008 financial crisis

admin
admin

Related Posts

Novo Nordisk shares dip as Wegovy maker posts earnings miss, cuts operating profit outlook

Novo Nordisk shares dip as Wegovy maker posts earnings ...

admin Aug 7, 2024  0  9

FDA approves two new Abbott over-the-counter continuous glucose monitors

FDA approves two new Abbott over-the-counter continuous...

admin Jun 11, 2024  0  11

Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

Eli Lilly to invest $1.8 billion to expand manufacturin...

admin Sep 12, 2024  0  14